DUBLIN, May 1, 2018 /PRNewswire/ -- Allergan plc (NYSE:AGN), a leading global biopharmaceutical company, today announced that Chief Financial Officer Matthew Walsh will present at the Deutsche Bank 43^rd Annual Health Care Conference in Boston, Massachusetts. The presentation will begin at 10:40 a.m. Eastern Time on Tuesday, May 8, 2018.

The presentation will be webcast live and can be accessed on Allergan's Investor Relations website at www.allergan.com/investors. The webcast can also be accessed through the following URL: https://edge.media-server.com/m6/p/28ksrw6d

An archived version will be available within approximately two hours of the live presentation, and can be accessed at the same location for 90 days.

About Allergan plc

Allergan plc (NYSE:AGN), headquartered in Dublin, Ireland, is a bold, global pharmaceutical leader. Allergan is focused on developing, manufacturing and commercializing branded pharmaceutical, device, biologic, surgical and regenerative medicine products for patients around the world.

Allergan markets a portfolio of leading brands and best-in-class products for the central nervous system, eye care, medical aesthetics and dermatology, gastroenterology, women's health, urology and anti-infective therapeutic categories.

Allergan is an industry leader in Open Science, a model of research and development, which defines our approach to identifying and developing game-changing ideas and innovation for better patient care. With this approach, Allergan has built one of the broadest development pipelines in the pharmaceutical industry.

Allergan's success is powered by our global colleagues' commitment to being Bold for Life. Together, we build bridges, power ideas, act fast and drive results for our customers and patients around the world by always doing what is right.

With commercial operations in approximately 100 countries, Allergan is committed to working with physicians, healthcare providers and patients to deliver innovative and meaningful treatments that help people around the world live longer, healthier lives every day.

For more information, visit Allergan's website at www.Allergan.com.

Forward-Looking Statement

Statements contained in this press release that refer to future events or other non-historical facts are forward-looking statements that reflect Allergan's current perspective on existing trends and information as of the date of this release. Actual results may differ materially from Allergan's current expectations depending upon a number of factors affecting Allergan's business. These factors include, among others, the difficulty of predicting the timing or outcome of FDA approvals or actions, if any; the impact of competitive products and pricing; market acceptance of and continued demand for Allergan's products; the impact of uncertainty around timing of generic entry related to key products, including RESTASIS^®, on our financial results; uncertainty associated with financial projections, projected cost reductions, projected synergies, restructurings, increased costs, and adverse tax consequences; difficulties or delays in manufacturing; and other risks and uncertainties detailed in Allergan's periodic public filings with the Securities and Exchange Commission, including but not limited to Allergan's Annual Report on Form 10-K for the year ended December 31, 2017. Except as expressly required by law, Allergan disclaims any intent or obligation to update these forward-looking statements.

CONTACTS:      
Allergan: 

Investors: 
Daphne Karydas 
(862) 261-8006

Karina Calzadilla 
(862) 261-7328

Media: 
Amy Rose 
(862) 289-3072

Lisa Brown 
(862) 261-7320

View original content with multimedia:http://www.prnewswire.com/news-releases/allergan-to-present-at-the-deutsche-bank-43rd-annual-health-care-conference-300640427.html

SOURCE Allergan plc